ARM

Understanding the Surge – Analyzing Arm's (ARM) Rise

Shares of Arm rose to $161.69 during today's afternoon trading session. Despite the 6.8% change, the Large-Cap Semiconductors company still trades 19.48% above its average analyst target price of $135.33. So there may be further downside for the Semiconductors stock. Arm has target prices ranging from $55.4 to $200.0 per share, and its average rating is buy.

The stock has an above average percentage of its shares sold short at 11.6%, and a short ratio of 2.22. The company's insiders own 88.05% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that a very small number of institutional investors are invested in the stock, with 6.3% of Arm's shares being owned by this investor type.

Institutions Invested in Arm

Date Reported Holder Percentage Shares Value
2024-06-30 Bank of America Corporation 1% 5,970,102 $965,305,806
2024-06-30 Goldman Sachs Group Inc 0% 4,348,183 $703,057,719
2024-06-30 Schroder Investment Management Group 0% 3,343,592 $540,625,398
2024-06-30 Artisan Partners Limited Partnership 0% 2,411,610 $389,933,226
2024-06-30 FMR, LLC 0% 2,271,287 $367,244,400
2024-06-30 Blackrock Inc. 0% 2,268,826 $366,846,481
2024-06-30 Shaw D.E. & Co., Inc. 0% 2,082,115 $336,657,179
2024-06-30 Alphabet Inc. 0% 1,960,784 $317,039,169
2024-06-30 Nvidia Corp 0% 1,960,784 $317,039,169
2024-06-30 Morgan Stanley 0% 2,009,728 $324,952,925

Besides an analyst belief that shares are overpriced, other market factors point to there being mixed market sentiment on Arm.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS